Comparing the effects of antimicrobial stewardship at primary emergency centers
Pediatrics International · 2023-01 · 65 (1)
DOI: 10.1111/ped.15614 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatrics International, 2023-09. Verfasst von Shogo Otake und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Department of Pediatrics, Kobe Children's Hospital, Kobe, Hyogo, Japan. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Anti-Infective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Background
Antimicrobial prescription rates tend to be high in outpatient settings and Primary Emergency Medical Centers (PECs) in Japan encounter difficulties in implementing antimicrobial stewardship programs (ASPs). While a nudge‐based ASP publishing monthly newsletters reduces inappropriate prescription of oral third‐generation cephalosporins (3GCs), which requires considerable effort. Therefore, developing more preferable ASP models in PECs is essential.
Methods
We conducted a three‐center, retrospective observational study. Himeji City Emergency Medical Center (Site A) introduced a facility‐specific guideline for antimicrobial stewardship with reference to national guidelines. The Kobe Children's Primary Emergency Medical Center (Site B) provided the results of monitoring antibiotics prescription in a monthly newsletter. The Hanshin‐Kita Children's First‐Aid Center (Site C) did not perform a specific ASP. Prescription rates for 3GCs were categorized into pre‐ and post‐intervention and compared using Poisson regression analysis. The difference‐in‐difference method was used to assess the effect of these interventions.
Results
The numbers of patients pre‐ and post‐ intervention were 177,126 and 91,251, respectively. The 3GCs prescription rate at Site A, Site B, and Site C decreased from 6.7%, 4.2%, and 6.1% in 2016 to 2.3%, 1.0%, and 2.0% in 2019, respectively. Site B had a greater reduction than Site A and Site C (relative risk [RR] 0.71 [95% confidence interval (CI): 0.62–0.82]; p < 0.001, RR 0.71, [95% CI: 0.62–0.81]; p < 0.001). There was no significant difference between Site A and Site C (RR 1.00 [95% CI 0.88–1.13]; p = 0.963).
Conclusion
A facility‐specific guideline was less effective than a nudge‐based ASP for decreasing oral 3GC prescriptions in PECs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Disease, Department of Pediatrics, Kobe Children's Hospital, Kobe, Hyogo, Japan.
- Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
- AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan.
- Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
- Department of Pharmacy, Kobe Children's Primary Emergency Medical Center, Kobe, Hyogo, Japan.
- Department of Pediatrics, Red Cross Society Himeji Hospital, Himeji, Hyogo, Japan.
ORCID-Profile: Shogo Otake, Yoshiki Kusama, Shinya Tsuzuki
Zitieren
APA
Otake, S., Kusama, Y., Tsuzuki, S., Myojin, S., Kimura, M., Kamiyoshi, N., Takumi, T., Ishida, A., & Kasai, M. (2023). Comparing the effects of antimicrobial stewardship at primary emergency centers. Pediatrics International, 65(1). https://doi.org/10.1111/ped.15614
Vancouver
Otake S, Kusama Y, Tsuzuki S, Myojin S, Kimura M, Kamiyoshi N, et al. Comparing the effects of antimicrobial stewardship at primary emergency centers. Pediatrics International. 2023;65(1). doi:10.1111/ped.15614
BibTeX
@article{Otake2023,
author = {Otake, Shogo and Kusama, Yoshiki and Tsuzuki, Shinya and Myojin, Shota and Kimura, Makoto and Kamiyoshi, Naohiro and Takumi, Toru and Ishida, Akihito and Kasai, Masashi},
title = {Comparing the effects of antimicrobial stewardship at primary emergency centers},
journal = {Pediatrics International},
year = {2023},
volume = {65},
number = {1},
doi = {10.1111/ped.15614}
}
EUVIMED